Stereotactic radiotherapy for oligometastatic cancer
Patients diagnosed with metastatic cancer are living longer due to advances in both systemic anti-cancer therapies and radiotherapy. Metastases from primary tumours cause morbidity and it is estimated that metastases are responsible for approximately 90% of all cancer deaths. The concept of oligometastatic disease (OMD) was first proposed in a seminal paper in 1995 by […]
Dr Emma Doyle, Dr Iain Phillips, Donna Burns
Edinburgh Cancer Centre, University of Edinburgh